Shots:Tim spoke about the development of THE-349, a fourth-generation small molecule for the treatment of EGFR-mutant NSCLCTim also talked about Thesus’ other small molecule, THE-630 in gastrointestinal stromal tumors (GIST) being evaluated in a P-I/II dose-escalation and expansion study The interview gives an understanding of how Thesus is developing different treatment options to…
